---  
layout: startup_page  
title: "Allay Therapeutics"  
id: "allaytx.com"  
permalink: "/allaytherapeuticsallaytx.com06052025/"  
website: "http://www.allaytx.com/"  
funding_round: "Series D & Venture Debt"  
funding_amount: "$57.5M"  
investors: "Lightstone Ventures, ClavystBio, NEA, Arboretum Ventures, Vertex Growth, Vertex Ventures Healthcare, Brandon Capital, IPD Capital, EDBI, SGInnovate, Maruishi Pharmaceutical, HSBC Innovation Banking"  
about: "Allay Therapeutics is a clinical-stage biotechnology company developing ultra-sustained analgesic products to transform post-surgical pain management. Their core mission is to reduce opioid use and improve patient recovery by delivering extended pain relief within a targeted site over weeks using their proprietary technology platform. ATX101, their novel investigational analgesic, is designed to provide extended pain relief after surgery."  
markets: "Biotech, Healthcare"  
hq: "San Jose, California, United States"  
founded_year: "2016"  
linkedin: "https://www.linkedin.com/company/allaytx"  
twitter: "https://twitter.com/allaytx"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/allay-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/466496-29"  

date_display: "05-Jun-2025"  
date: "2025-06-05"

# SEO Optimization  
meta_title: "Allay Therapeutics - Series D & Venture Debt Funding ($57.5M)"  
meta_description: "Allay Therapeutics, Allay Therapeutics is a clinical-stage biotechnology company developing ultra-sustained analgesic products to transform post-surgical pain management...."  
meta_keywords: "Allay Therapeutics, Biotech, Healthcare, Series D & Venture Debt funding"  
canonical_url: "https://startup.projectstartups.com/allaytherapeuticsallaytx.com06052025/"  
---